Bernhard H. Monien, Ph.D.

Affiliations: 
Ernährungstoxikologie Deutsches Institut für Ernährungsforschung, Nuthetal, Brandenburg, Germany 
Area:
Alzheimer's disease
Google:
"Bernhard Monien"
Mean distance: 15638.9 (cluster 32)
 
Cross-listing: Alzheimer's Tree

Parents

Sign in to add mentor
Gal Bitan post-doc 2005-2007 UCLA
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Li H, Zemel R, Lopes DH, et al. (2012) A two-step strategy for structure-activity relationship studies of N-methylated aβ42 C-terminal fragments as aβ42 toxicity inhibitors. Chemmedchem. 7: 515-22
Urbanc B, Betnel M, Cruz L, et al. (2011) Structural basis for Aβ1–42 toxicity inhibition by Aβ C-terminal fragments: discrete molecular dynamics study. Journal of Molecular Biology. 410: 316-28
Li H, Monien BH, Lomakin A, et al. (2010) Mechanistic investigation of the inhibition of Abeta42 assembly and neurotoxicity by Abeta42 C-terminal fragments. Biochemistry. 49: 6358-64
Li H, Monien BH, Fradinger EA, et al. (2010) Biophysical characterization of Abeta42 C-terminal fragments: inhibitors of Abeta42 neurotoxicity. Biochemistry. 49: 1259-67
Condron MM, Monien BH, Bitan G. (2008) Synthesis and Purification of Highly Hydrophobic Peptides Derived from the C-Terminus of Amyloid β-Protein. The Open Biotechnology Journal. 2: 87-93
Fradinger EA, Monien BH, Urbanc B, et al. (2008) C-terminal peptides coassemble into Abeta42 oligomers and protect neurons against Abeta42-induced neurotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 105: 14175-80
Monien BH, Apostolova LG, Bitan G. (2006) Early diagnostics and therapeutics for Alzheimer's disease--how early can we get there? Expert Review of Neurotherapeutics. 6: 1293-306
See more...